Paul Perito, COB and COO of STSI, and a very experienced securities and complex litigation attorney, twice did about the same thing as HB to defend his company in the last few days, but via PRs. E.g.:
Well, ARIA is NOT the first development stage biotech transitioning to commercial biotech going through this. INCY, SGEN to name a couple, had gone through almost exactly same process, they had dealt with in much more measured and professional response!
News 
Market Data 
Discover 
